**Core Concept**
The patient's symptoms and examination findings are indicative of a central serous chorioretinopathy (CSCR), a condition characterized by the accumulation of fluid under the retina in the macula, leading to visual disturbances such as metamorphopsia and decreased central vision. The "smoke stack" sign on fluorescein angiography is a classic finding in CSCR.

**Why the Correct Answer is Right**
The management of CSCR typically involves observation, as most cases resolve spontaneously within 3-6 months. However, in some cases, treatment may be necessary to alleviate symptoms and promote faster recovery. The "smoke stack" sign is indicative of a more active or severe form of CSCR, which may require treatment. The correct answer is photodynamic therapy (PDT) with verteporfin, which involves the administration of a light-sensitive medication followed by exposure to a low-intensity laser. This treatment helps to reduce the leakage of fluid from the choroidal vessels and promote healing of the retina.

**Why Each Wrong Option is Incorrect**
**Option A:** Laser photocoagulation is not typically used in the management of CSCR, as it can cause further damage to the retina. This option is incorrect because laser photocoagulation is not the preferred treatment for CSCR.
**Option B:** Anti-vascular endothelial growth factor (anti-VEGF) therapy is not the first-line treatment for CSCR, although it may be used in some cases. This option is incorrect because anti-VEGF therapy is not the standard treatment for CSCR.
**Option C:** Corticosteroids are not typically used in the management of CSCR, as they can have systemic side effects and may not be effective in reducing the leakage of fluid from the choroidal vessels. This option is incorrect because corticosteroids are not the preferred treatment for CSCR.

**Clinical Pearl / High-Yield Fact**
The "smoke stack" sign on fluorescein angiography is a classic finding in CSCR, indicating the presence of a choroidal neovascular membrane. This sign is associated with a more active or severe form of the disease and may require treatment to prevent further vision loss.

**Correct Answer:** C. Photodynamic therapy with verteporfin.